Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: August 19, 2022

WOMEN'S ROGAINE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which patents cover Women's Rogaine, and what generic alternatives are available?

Women's Rogaine is a drug marketed by Johnson And Johnson and is included in one NDA.

The generic ingredient in WOMEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Women's Rogaine

A generic version of WOMEN'S ROGAINE was approved as minoxidil by WATSON LABS on March 3rd, 1987.

  Try it Free

Drug patent expirations by year for WOMEN'S ROGAINE
Recent Clinical Trials for WOMEN'S ROGAINE

Identify potential brand extensions & 505(b)(2) entrants

Ohio State University Comprehensive Cancer CenterEarly Phase 1
Loyola UniversityPhase 2
Cures Within ReachPhase 2

See all WOMEN'S ROGAINE clinical trials

Pharmacology for WOMEN'S ROGAINE
Paragraph IV (Patent) Challenges for WOMEN'S ROGAINE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
WOMEN'S ROGAINE Topical Aerosol Foam minoxidil 5% 021812 1 2015-02-04
WOMEN'S ROGAINE Topical Aerosol Foam minoxidil 5% 021812 1 2009-04-06

US Patents and Regulatory Information for WOMEN'S ROGAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson WOMEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-002 Feb 28, 2014 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for WOMEN'S ROGAINE

See the table below for patents covering WOMEN'S ROGAINE around the world.

Country Patent Number Title Estimated Expiration
Portugal 1073439 See Plans and Pricing
Japan 4338455 See Plans and Pricing
World Intellectual Property Organization (WIPO) 9953923 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.